A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota

The incidence and prevalence of inflammatory bowel disease (IBD) increases steadily worldwide. There is an urgent need for effective and safe IBD therapies. Accelerated resolution of inflammation is a new strategy for the management of inflammatory diseases. For effective and safe IBD treatment, her...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenwen, Zhao, Yang, Cheng, Juan, Guo, Jiawei, Zhang, Qixiong, Zhang, Xiangjun, Ren, Jiong, Wang, Fengchao, Huang, Jun, Hu, Houyuan, Wang, Ruibing, Zhang, Jianxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755521/
https://www.ncbi.nlm.nih.gov/pubmed/31559126
http://dx.doi.org/10.1002/advs.201900610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755521/
https://www.ncbi.nlm.nih.gov/pubmed/31559126
http://dx.doi.org/10.1002/advs.201900610

Ejemplares similares